Literature DB >> 15339047

Laminin-5 in epithelial tumour invasion.

Masahiko Katayama1, Kiyotoshi Sekiguchi.   

Abstract

Laminin-5 (LN-5), consisting of alpha3-, beta3-, and gamma2-chains, is a component of the cell adhesion complex containing hemidesmosomes and anchoring fibrils. This protein is a major constituent of the extracellular matrix and has recently proved to be an invasion marker for epithelial cells in many immunohistochemical surveys, indicating that it is frequently expressed in the invading edges of epithelial tumour cells. Additionally, intracellular accumulation of monomeric gamma2-chains has been widely observed in the invasive carcinoma cells, but its mechanism was not entirely understood. Epithelial carcinoma cells prefer to adhere onto the LN-5-rich basement membranes using the specific integrins as receptors. Induction of cell migration is an important function of LN-5 and the enhanced activity is observed in its truncated form after proteolytic shedding of the N-terminal fragments of gamma2-chains. This processing was demonstrated to be mediated mainly by several kinds of matrix metalloproteinases. The degraded fragments of gamma2-chains, released from invading carcinomas, can be immunodetected in biological fluids and potentially utilized in the clinical diagnosis of various epithelial cancers. Here, we summarize the previous clinical investigations of LN-5 in epithelial tumour progression, and also discuss what it can regulate in the cell physiological events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339047     DOI: 10.1023/b:hijo.0000032359.35698.fe

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  100 in total

1.  Traction forces mediated by alpha6beta4 integrin: implications for basement membrane organization and tumor invasion.

Authors:  I Rabinovitz; I K Gipson; A M Mercurio
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

2.  Dynamics of the alpha6beta4 integrin in keratinocytes.

Authors:  Cecile A W Geuijen; Arnoud Sonnenberg
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  Can alterations in integrin and laminin-5 expression be used as markers of malignancy?

Authors:  A K Thorup; J Reibel; M Schiødt; T C Stenersen; M H Therkildsen; W G Carter; E Dabelsteen
Journal:  APMIS       Date:  1998-12       Impact factor: 3.205

4.  Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin.

Authors:  Dallas P Veitch; Pasi Nokelainen; Kelly A McGowan; Thuong-Thuong Nguyen; Ngon E Nguyen; Robert Stephenson; William N Pappano; Douglas R Keene; Suzanne M Spong; Daniel S Greenspan; Paul R Findell; M Peter Marinkovich
Journal:  J Biol Chem       Date:  2002-12-07       Impact factor: 5.157

5.  Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.

Authors:  H Yamamoto; F Itoh; S Iku; M Hosokawa; K Imai
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

6.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

7.  Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.

Authors:  J Hao; Y Yang; K M McDaniel; B L Dalkin; A E Cress; R B Nagle
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  Defective laminin 5 processing in cylindroma cells.

Authors:  Lucy Tunggal; Juliette Ravaux; Monika Pesch; Hans Smola; Thomas Krieg; Françoise Gaill; Takako Sasaki; Rupert Timpl; Cornelia Mauch; Monique Aumailley
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

9.  The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4.

Authors:  C Van Waes; K F Kozarsky; A B Warren; L Kidd; D Paugh; M Liebert; T E Carey
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

10.  Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases.

Authors:  W H Kim; M Nomizu; S Y Song; K Tanaka; Y Kuratomi; H K Kleinman; Y Yamada
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  34 in total

1.  Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization.

Authors:  Bernd U Sehgal; Phillip J DeBiase; Sumio Matzno; Teng-Leong Chew; Jessica N Claiborne; Susan B Hopkinson; Alan Russell; M Peter Marinkovich; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2006-09-14       Impact factor: 5.157

Review 2.  Laminin isoforms in development and disease.

Authors:  Susanne Schéele; Alexander Nyström; Madeleine Durbeej; Jan F Talts; Marja Ekblom; Peter Ekblom
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 3.  Bridging structure with function: structural, regulatory, and developmental role of laminins.

Authors:  Julia Tzu; M Peter Marinkovich
Journal:  Int J Biochem Cell Biol       Date:  2007-08-06       Impact factor: 5.085

Review 4.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front.

Authors:  Marcus Franz; Torsten Hansen; Petra Richter; Laura Borsi; Frank-D Böhmer; Peter Hyckel; Peter Schleier; Detlef Katenkamp; Luciano Zardi; Hartwig Kosmehl; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2005-12-13       Impact factor: 4.304

6.  Laminin 332 expression in breast carcinoma.

Authors:  Soon-Young Kwon; Seoung W Chae; Sharon P Wilczynski; Ahmad Arain
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-03

7.  Laminin-based cell adhesion anchors microtubule plus ends to the epithelial cell basal cortex through LL5alpha/beta.

Authors:  Azusa Hotta; Tomomi Kawakatsu; Tomoya Nakatani; Toshitaka Sato; Chiyuki Matsui; Taiko Sukezane; Tsuyoshi Akagi; Tomoko Hamaji; Ilya Grigoriev; Anna Akhmanova; Yoshimi Takai; Yuko Mimori-Kiyosue
Journal:  J Cell Biol       Date:  2010-05-31       Impact factor: 10.539

8.  Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2.

Authors:  Dirk Zboralski; Bettina Warscheid; Susanne Klein-Scory; M Bassel Malas; Heiko Becker; Miriam Böckmann; Helmut E Meyer; Wolff Schmiegel; Patricia Simon-Assmann; Irmgard Schwarte-Waldhoff
Journal:  Mol Cancer       Date:  2010-03-22       Impact factor: 27.401

9.  Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5).

Authors:  Go Kamoshida; Takashi Ogawa; Jun Oyanagi; Hiroki Sato; Eriko Komiya; Shouichi Higashi; Kaoru Miyazaki; Tsutomu Tsuji
Journal:  Clin Exp Metastasis       Date:  2013-12-01       Impact factor: 5.150

10.  Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury.

Authors:  Masahiko Katayama; Akitoshi Ishizaka; Michiie Sakamoto; Seitaro Fujishima; Kiyotoshi Sekiguchi; Koichiro Asano; Tomoko Betsuyaku; Toru Kotani; Lorraine B Ware; Michael A Matthay; Satoru Hashimoto
Journal:  Intensive Care Med       Date:  2009-11-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.